Zoetis | ZTS - Gross Profit On Sales

Stock Price
116.65
Daily Change
-1.22 -1.04%
Monthly
0.28%
Yearly
-24.95%
Q2 Forecast
114.37

Zoetis reported $1.64B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Align Technology USD 683.59M 44.39M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Coherus Biosciences USD 8.7M 853K Dec/2025
Dentsply International USD 443M 2M Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Henry Schein USD 1.06B 37M Dec/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Illumina USD 759M 26M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
J&J USD 17.24B 642M Mar/2026
Laboratory Of America USD 993.2M 31.9M Dec/2025
Merck USD 13.42B 431M Sep/2025
Neogen USD 99M 7.7M Dec/2025
Pacira USD 142.25M 11.34M Dec/2025
Perrigo USD 362.2M 14.9M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Sanofi EUR 8.45B 1.31B Dec/2025
Sanofi EUR 8.45B 3.02B Dec/2025
Zoetis USD 1.64B 73M Dec/2025